QUICK READ: Pharma CEOs, because of compensation, put shareholders first at the expense of patients. AbbVie’s CEO is compensated based on Humira’s patent protection. Wall Street doesn’t really understand the…
The public doesn’t trust pharma
QUICK READ: The February 2019 KFF Health Tracking Poll finds a majority of adults, including seniors, are in favor of many policy options aimed at curbing prescription drug costs. There…
Cancer patients are living longer but it comes with financial pain.
QUICK READ: Scientists say lower smoking rates, earlier detection, and better drugs are responsible for a steady decline in cancer deaths since 1991. The U.S. cancer death rate dropped 2.2…
Millennials aren’t prepared for aging parents
QUICK READ: Caring for an aging parent is a compassionate—but often stressful—undertaking. It can take a huge emotional toll on everyone in a family, but for women, who are far…
AbbVie is proof that it’s about profits, not patients
QUICK READ: AbbVie, Humira’s manufacturer, kicked off 2020 with a price increase in excess of 7 percent on its mega-blockbuster brand-name treatment. The increase followed total Humira price hikes of 19 percent…
DTC advertising in a post-truth world
KEY IDEA: We live in a post-truth world. The institutions that were once trusted sources of truths are now regarded with deep skepticism by citizens and consumers alike. That’s changing…
Obesity: America’s Self-inflicted Preexisting Condition
SUMMARY: The American Medical Association has declared that obesity is a disease According to the CDC’s last comprehensive analysis, the annual medical cost of obesity in the United States to Medicare, Medicaid,…
eHealth is a tool, not a replacement for HCPs
SUMMARY eHealth reality doesn’t quite live up to the promise. Even the Apple Watch studies are in doubt. We need data on what people do as a result of eHealth…